Novel Diagnosis and Therapeutics Approaches in Retina Diseases—2nd Edition
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 259
Special Issue Editors
Interests: vitreoretinal surgery; cataratct surgery; retinal prosthesis
Special Issues, Collections and Topics in MDPI journals
Interests: medical and surgical retina; cataract surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This second volume of this Special Issue follows on from the success of the first. We invite you to publish your research in this edition of “Novel Diagnosis and Therapeutics Approaches in Retina Diseases” (https://www.mdpi.com/journal/life/special_issues/68556WR3U8).
Basic clinical research continuously provides novel insights in the field of retina disorders, and novel imaging tools contribute to more in-depth and early diagnoses. In addition, vitreoretinal surgery is becoming progressively less traumatic and more effective in treating an ever-wider number of pathologies. Moreover, nonsurgical therapies are gaining increasingly more attention; novel drugs, gene therapy, optogenetics, retinal prosthesis, etc., represent concrete hopes for diseases considered incurable up till now. For this reason, it is essential that good ideas and novel insights are shared among scientists, mainly in the interest of patients.
The aim of this Special Issue is to present as wide a range of innovations as possible in the field of retina disorder diagnosis and therapy; thus, we encourage the submission of manuscripts covering topics from basic research to the description of intriguing clinical cases.
Dr. Maurizio Mete
Dr. Emilia Maggio
Dr. Alessandro Alfano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retina disorders
- vitreoretinal surgery
- medical retina
- anti-VEGF
- gene therapy
- optogenetics
- retinal prosthesis
- OCT
- OCT angiography
- retinal imaging
